I would just call it murder...
these 'new' covid shots have NOT BEEN TESTED ON HUMANS...
DON'T BE THEIR GUINEA PIG...
Aug 22, 2022 — Pfizer's application to authorize the vaccine without new clinical trial data is part of a bold and potentially controversial gambit.
Pfizer and BioNTech said Monday that they have asked the Food and Drug Administration to authorize a new booster shot targeted at the Omicron BA.4/BA.5 strain of the coronavirus that causes Covid-19, the first step in a process that could lead to more effective booster shots.
Notably, in the same press release, the companies said that a clinical study investigating the safety, tolerability, and immunogenicity of the vaccine, which also includes the original Covid strain, is expected to start this month, meaning data would not be available for the FDA to consider.
So the FDA and its advisers have backed a plan that argues that enough is now known about the Moderna and Pfizer/BioNTech platforms to approve booster shots before clinical data are available.
these 'new' covid shots have NOT BEEN TESTED ON HUMANS...
DON'T BE THEIR GUINEA PIG...
Pfizer seeks authorization for updated Covid vaccine, without ...
https://www.statnews.com › 2022/08/22 › pfizer-seeks-...Aug 22, 2022 — Pfizer's application to authorize the vaccine without new clinical trial data is part of a bold and potentially controversial gambit.
Pfizer and BioNTech said Monday that they have asked the Food and Drug Administration to authorize a new booster shot targeted at the Omicron BA.4/BA.5 strain of the coronavirus that causes Covid-19, the first step in a process that could lead to more effective booster shots.
Notably, in the same press release, the companies said that a clinical study investigating the safety, tolerability, and immunogenicity of the vaccine, which also includes the original Covid strain, is expected to start this month, meaning data would not be available for the FDA to consider.
So the FDA and its advisers have backed a plan that argues that enough is now known about the Moderna and Pfizer/BioNTech platforms to approve booster shots before clinical data are available.